TY  - JOUR

T1  - Long‐term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: pooled 52‐week outcomes from the DEPICT‐1 and ‐2 studies outcomes from the DEPICT‐1 and ‐2 studies

JO  - Diabetes, Obesity and Metabolism

UR  - http://eprints.whiterose.ac.uk/169674/

PY  - 2021/02/01

AU  - Phillip M

AU  - Mathieu C

AU  - Lind M

AU  - Araki E

AU  - Bartolo P

AU  - Bergenstal R

AU  - Heller S

AU  - Hansen L

AU  - Scheerer MF

AU  - Thoren F

AU  - Arya N et al

ED  - 

DO  - DOI: 10.1111/dom.14248

PB  - Wiley

VL  - 23

IS  - 2

SP  - 549

EP  - 560

Y2  - 2024/10/22

ER  -